Portal hypothesis
Portal Hypothesis
The Portal Hypothesis is a medical theory that suggests a direct link between the gut and the liver in the pathogenesis of type 2 diabetes and non-alcoholic fatty liver disease (NAFLD). This theory is based on the observation that substances absorbed from the gut directly enter the liver through the portal vein before being distributed to the rest of the body.
Overview
The Portal Hypothesis proposes that an increase in the delivery of free fatty acids (FFAs) and other nutrients to the liver from the gut, due to overnutrition or poor diet, can lead to insulin resistance and the development of NAFLD. This is thought to occur due to the overproduction of glucose and lipids in the liver, leading to hyperglycemia and hyperlipidemia, which are key features of type 2 diabetes and NAFLD.
Mechanism
The mechanism of the Portal Hypothesis involves the insulin resistance that occurs in the liver. When there is an excess of FFAs and other nutrients, the liver becomes resistant to insulin, leading to an increase in the production of glucose and lipids. This results in the accumulation of fat in the liver, leading to NAFLD, and the increase in blood glucose levels, leading to type 2 diabetes.
Clinical Implications
The Portal Hypothesis has significant clinical implications. It suggests that interventions aimed at reducing the delivery of FFAs and other nutrients to the liver, such as dietary changes or medications that reduce gut absorption, could be effective in preventing or treating type 2 diabetes and NAFLD.
Criticisms
While the Portal Hypothesis is widely accepted, it has been criticized for its simplicity. Some researchers argue that it does not fully explain the complex interplay between the gut, liver, and other organs in the development of type 2 diabetes and NAFLD. Further research is needed to fully understand the mechanisms involved.
See Also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD